ArticleNeurosurgical review2025
The role of intraoperative flow cytometry on intracranial tumor surgery : a scoping review.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this review is to present the role of intraoperative flow cytometry (IFC) in the intracranial tumor surgery. This scoping review aims to summarize current evidence on the intraoperative use of IFC in patients with intracranial tumors.
methodsA comprehensive literature search was conducted in the Medline, Cochrane and Scopus databases up to January 21, 2025. Data extraction was carried out following the use of preset inclusion and exclusion criteria.
resultsA total of 14 studies were analyzed in this review, involving 1.043 patients with intracranial tumors to assess the utility of IFC in the rapid diagnosis of these tumors. The studies evaluated IFC for grading gliomas and meningiomas, distinguishing tumor margins, determining tumor prognosis, and its application in pediatric tumors, metastases, and primary central nervous system lymphomas. The most promising applications of IFC are in glioma and meningioma grading, as well as in identifying glioma margins. IFC appears to be a valuable intraoperative tool for intracranial tumor classification, providing rapid results within minutes.
conclusionIFC shows potential as a real-time, intraoperative tool for brain tumor classification and surgical guidance. Nevertheless, studies in this field are limited, and further research with more robust data is needed to establish specific cut-off values that will enable reliable conclusions.
Indexed as
Identifiers
40924253What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.